Marietta Anthony

488 total citations
15 papers, 368 citations indexed

About

Marietta Anthony is a scholar working on Pharmacology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Marietta Anthony has authored 15 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 5 papers in Genetics and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Marietta Anthony's work include Estrogen and related hormone effects (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Menopause: Health Impacts and Treatments (4 papers). Marietta Anthony is often cited by papers focused on Estrogen and related hormone effects (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Menopause: Health Impacts and Treatments (4 papers). Marietta Anthony collaborates with scholars based in United States, United Kingdom and Mexico. Marietta Anthony's co-authors include Mary J. Berg, Raymond L. Woosley, Daniel C. Malone, Klaus Romero, Marlene P. Freeman, Banu Arun, Barbara Dunn, Lisa E. Hines, Karen Fried and Paul E. Nolan and has published in prestigious journals such as Annals of the New York Academy of Sciences, Clinical Pharmacology & Therapeutics and Clinical Therapeutics.

In The Last Decade

Marietta Anthony

15 papers receiving 349 citations

Peers

Marietta Anthony
Pipasha Biswas United Kingdom
Matthew Tuck United States
Leland E. Hull United States
Dipak Kanabar United Kingdom
Taco B. M. Monster Netherlands
Olaf H. Klungel Netherlands
Fei Tang United States
Pipasha Biswas United Kingdom
Marietta Anthony
Citations per year, relative to Marietta Anthony Marietta Anthony (= 1×) peers Pipasha Biswas

Countries citing papers authored by Marietta Anthony

Since Specialization
Citations

This map shows the geographic impact of Marietta Anthony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marietta Anthony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marietta Anthony more than expected).

Fields of papers citing papers by Marietta Anthony

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marietta Anthony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marietta Anthony. The network helps show where Marietta Anthony may publish in the future.

Co-authorship network of co-authors of Marietta Anthony

This figure shows the co-authorship network connecting the top 25 collaborators of Marietta Anthony. A scholar is included among the top collaborators of Marietta Anthony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marietta Anthony. Marietta Anthony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Hines, Lisa E., Klaus Romero, Marietta Anthony, et al.. (2011). Evaluation of Warfarin Drug Interaction Listings in US Product Information for Warfarin and Interacting Drugs. Clinical Therapeutics. 33(1). 36–45. 19 indexed citations
2.
Fried, Karen, Paul E. Nolan, Marietta Anthony, Raymond L. Woosley, & Marlene P. Freeman. (2011). LC–MS Analysis of Sertraline and Its Active Metabolite in Human Serum Using a Silica Column with a Non-Aqueous Polar Mobile Phase. Chromatographia. 73(7-8). 749–754. 8 indexed citations
3.
Anthony, Marietta, Klaus Romero, Daniel C. Malone, et al.. (2009). Warfarin Interactions With Substances Listed in Drug Information Compendia and in the FDA-Approved Label for Warfarin Sodium. Clinical Pharmacology & Therapeutics. 86(4). 425–429. 37 indexed citations
4.
Romero, Klaus, Denise Frank, Marietta Anthony, et al.. (2009). The Coalition Against Major Diseases: Developing Tools for an Integrated Drug Development Process for Alzheimer’s and Parkinson’s Diseases. Clinical Pharmacology & Therapeutics. 86(4). 365–367. 27 indexed citations
5.
Freeman, Marlene P., Paul E. Nolan, Melinda F. Davis, et al.. (2008). Pharmacokinetics of Sertraline Across Pregnancy and Postpartum. Journal of Clinical Psychopharmacology. 28(6). 646–653. 51 indexed citations
6.
Anthony, Marietta, Jacob Abarca, Rick A. Rehfeld, et al.. (2008). Gender and Age Differences in Medications Dispensed from a National Chain Drugstore. Journal of Women s Health. 17(5). 735–743. 27 indexed citations
7.
Anthony, Marietta. (2005). Male/Female Differences in Pharmacology: Safety Issues with QT-Prolonging Drugs. Journal of Women s Health. 14(1). 47–52. 18 indexed citations
8.
Anthony, Marietta & Mary J. Berg. (2002). Biologic and Molecular Mechanisms for Sex Differences in Pharmacokinetics, Pharmacodynamics and Pharmacogenetics: Part II. Journal of Women s Health & Gender-Based Medicine. 11(7). 617–629. 44 indexed citations
9.
Anthony, Marietta & Mary J. Berg. (2002). Biologic and Molecular Mechanisms for Sex Differences in Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics: Part I. Journal of Women s Health & Gender-Based Medicine. 11(7). 601–615. 81 indexed citations
10.
Dunn, Barbara, Marietta Anthony, & Banu Arun. (2002). The search for the ideal SERM. Expert Opinion on Pharmacotherapy. 3(6). 681–691. 28 indexed citations
11.
Anthony, Marietta. (2001). Selective estrogen receptor modulators (SERMs). New York Academy of Sciences eBooks. 1 indexed citations
12.
Anthony, Marietta & Karen L. Johnson. (2001). Roles of Industry, Government, and Academia in SERM Development. Annals of the New York Academy of Sciences. 949(1). 315–316. 2 indexed citations
13.
Anthony, Marietta, J. Koudy Williams, & Barbara K. Dunn. (2001). What Would Be the Properties of an Ideal SERM?. Annals of the New York Academy of Sciences. 949(1). 261–278. 20 indexed citations
14.
Johnson, Susan R., Barbara K. Dunn, & Marietta Anthony. (2001). Defining Benefits and Risks for SERMs in Clinical Trials and Clinical Practice. Annals of the New York Academy of Sciences. 949(1). 304–314. 3 indexed citations
15.
Dunn, Barbara K., Marietta Anthony, Sherry Sherman, & Joseph P. Costantino. (2001). Conclusions. Annals of the New York Academy of Sciences. 949(1). 352–365. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026